|
1
|
Nasioudis D, Sisti G, Kanninen TT, Holcomb
K, Di Tommaso M, Fambrini M and Witkin SS: Epidemiology and
outcomes of squamous ovarian carcinoma; a population-based study.
Gynecol Oncol. 2016. View Article : Google Scholar
|
|
2
|
Kosary CL: FIGO stage, histology,
histologic grade, age and race as prognostic factors in determining
survival for cancers of the female gynecological system: An
analysis of 1973–87 SEER cases of cancers of the endometrium,
cervix, ovary, vulva, and vagina. Semin Surg Oncol. 10:31–46. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jiang J, Xie W and Cao J: Current
situation of the therapies of middle-advanced ovarian cancer. Zhong
Liu Yao Xue. 3:416–421. 2013.In Chinese.
|
|
4
|
He JR, Gao X and Ren ZF: Global Incidence
Patterns of Female Breast and Ovarian Cancers. China Cancer.
3:169–172. 2009.
|
|
5
|
Lou JY, Peng ZL, Zheng Y, Wang H, He B and
Wang HJ: Research on human ovarian cancer cell MDR1 gene silenced
by siRNA. Sichuan Da Xue Xue Bao Yi Xue Ban. 38:753–755. 2007.In
Chinese. PubMed/NCBI
|
|
6
|
Menendez L, Walker D, Matyunina LV,
Dickerson EB, Bowen NJ, Polavarapu N, Benigno BB and McDonald JF:
Identification of candidate methylation-responsive genes in ovarian
cancer. Mol Cancer. 6:102007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tei H, Okamura H, Shigeyoshi Y, Fukuhara
C, Ozawa R, Hirose M and Sakaki Y: Circadian oscillation of a
mammalian homologue of the Drosophila period gene. Nature.
389:512–516. 1997. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shigeyoshi Y, Taguchi K, Yamamoto S,
Takekida S, Yan L, Tei H, Moriya T, Shibata S, Loros JJ, Dunlap JC
and Okamura H: Light-induced resetting of a mammalian circadian
clock is associated with rapid induction of the mPer1 transcript.
Cell. 91:1043–1053. 1997. View Article : Google Scholar
|
|
9
|
Jin X, Shearman LP, Weaver DR, Zylka MJ,
de Vries GJ and Reppert SM: A molecular mechanism regulating
rhythmic output from the suprachiasmatic circadian clock. Cell.
96:57–68. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Reppert SM and Weaver DR: Molecular
analysis of mammalian circadian rhythms. Annu Rev Physiol.
63:647–676. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Young MW and Kay SA: Time zones: A
comparative genetics of circadian clocks. Nat Rev Genet. 2:702–715.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bjarnason GA and Jordan R: Circadian
variation of cell proliferation and cell cycle protein expression
in man: Clinical implications. Prog Cell Cycle Res. 4:193–206.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Matsuo T, Yamaguchi S, Mitsui S, Emi A,
Shimoda F and Okamura H: Control mechanism of the circadian clock
for timing of cell division in vivo. Science. 302:255–259. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Panda S, Antoch MP, Miller BH, Su AI,
Schook AB, Straume M, Schultz PG, Kay SA, Takahashi JS and
Hogenesch JB: Coordinated transcription of key pathways in the
mouse by the circadian clock. Cell. 109:307–320. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Barbason H, Herens C, Robaye B, Milis G,
Sulon J, Bouzahzah B and VanCantfort J: Importance of cell kinetics
rhythmicity for the control of cell proliferation and
carcinogenesis in rat liver (review). In Vivo. 9:539–548.
1995.PubMed/NCBI
|
|
16
|
Hansen J: Increased breast cancer risk
among women who work predominantly at night. Epidemiology.
12:74–77. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lee CC: Tumor suppression by the mammalian
Period genes. Cancer Causes Control. 17:525–530. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fu L, Pelicano H, Liu J, Huang P and Lee
C: The circadian gene Period2 plays an important role in tumor
suppression and DNA damage response in vivo. Cell. 111:41–50. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gery S, Komatsu N, Baldjyan L, Yu A, Koo D
and Koeffler HP: The circadian gene per1 plays an important role in
cell growth and DNA damage control in human cancer cells. Mol Cell.
22:375–382. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pecorelli S, Benedet JL, Creasman WT and
Shepherd JH; FIGO staging of gynecologic cancer; 1994–1997 FIGO
committee on Gynecologic Oncology: International Federation of
Gynecology and Obstetrics. Int J Gynaecol Obstet. 65:243–249. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pfaffl MW: A new mathematical model for
relative quantification in real-time RT-PCR. Nucleic Acids Res.
29:e452001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Karantanos T, Theodoropoulos G, Pektasides
D and Gazouli M: Clock genes: Their role in colorectal cancer.
World J Gastroenterol. 20:1986–1992. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chi C, He ZF, Liu Y, Lin XM and Sun CC:
Expression and clinical significance of circadian gene Per2 in
non-small cell lung cancer. Zhonghua Zhong Liu Za Zhi. 35:129–131.
2013.In Chinese. PubMed/NCBI
|
|
24
|
Yang X, Wood PA, Oh EY, Du-Quiton J,
Ansell CM and Hrushesky WJ: Down regulation of circadian clock gene
Period 2 accelerates breast cancer growth by altering its daily
growth rhythm. Breast Cancer Res Treat. 117:423–431. 2009.
View Article : Google Scholar
|
|
25
|
Koyanagi S, Kuramoto Y, Nakagawa H,
Aramaki H, Ohdo S, Soeda S and Shimeno H: A molecular mechanism
regulating circadian expression of vascular endothelial growth
factor in tumor cells. Cancer Res. 63:7277–7283. 2003.PubMed/NCBI
|
|
26
|
Toh Y, Oki E, Oda S, Tokunaga E, Ohno S,
Maehara Y, Nicolson GL and Sugimachi K: Overexpression of the MTA1
gene in gastrointestinal carcinomas: Correlation with invasion and
metastasis. Int J Cancer. 74:459–463. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Talukder AH, Mishra SK, Mandal M,
Balasenthil S, Mehta S, Sahin AA, Barnes CJ and Kumar R: MTA1
interacts with MAT1, a cyclin-dependent kinase-activating kinase
complex ring finger factor, and regulates estrogen receptor
transactivation functions. J Biol Chem. 278:11676–11685. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Avtanski DB, Nagalingam A, Kuppusamy P,
Bonner MY, Arbiser JL, Saxena NK and Sharma D: Honokiol abrogates
leptin-induced tumor progression by inhibiting Wnt1-MTA1-β-catenin
signaling axis in a microRNA-34a dependent manner. Oncotarget.
6:16396–16410. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Marzook H, Deivendran S, Kumar R and
Pillai MR: Role of MTA1 in head and neck cancers. Cancer Metastasis
Rev. 33:953–964. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bruning A, Blankenstein T, Jückstock J and
Mylonas I: Function and regulation of MTA1 and MTA3 in malignancies
of the female reproductive system. Cancer Metastasis Rev.
33:943–951. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Deng X, Du L, Wang C, Yang Y, Li J, Liu H,
Zhang J, Wang L, Zhang X, Li W, et al: Close association of
metastasis-associated protein 1 overexpression with increased
angiogenesis and poor survival in patients with histologically
node-negative gastric cancer. World J Surg. 37:792–798. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Martin MD, Hilsenbeck SG, Mohsin SK, Hopp
TA, Clark GM, Osborne CK, Allred DC and O'Connell P: Breast tumors
that overexpress nuclear metastasis-associated 1 (MTA1) protein
have high recurrence risks but enhanced responses to systemic
therapies. Breast Cancer Res Treat. 95:7–12. 2006. View Article : Google Scholar
|
|
33
|
Cheng CW, Liu YF, Yu JC, Wang HW, Ding SL,
Hsiung CN, Hsu HM, Shieh JC, Wu PE and Shen CY: Prognostic
significance of cyclin D1, β-catenin, and MTA1 in patients with
invasive ductal carcinoma of the breast. Ann Surg Oncol.
19:4129–4139. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang H, Zhu X, Li N, Li D, Sha Z, Zheng X
and Wang H: miR-125a-3p targets MTA1 to suppress NSCLC cell
proliferation, migration, and invasion. Acta Biochim Biophys Sin.
47:496–503. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kawasaki G, Yanamoto S, Yoshitomi I,
Yamada S and Mizuno A: Overexpression of metastasis-associated MTA1
in oral squamous cell carcinomas: Correlation with metastasis and
invasion. Int J Oral Maxillofac Surg. 37:1039–1046. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gilles AM, Presecan E, Vonica A and Lascu
I: Nucleoside diphosphate kinase from human erythrocytes.
Structural characterization of the two polypeptide chains
responsible for heterogeneity of the hexameric enzyme. J Biol Chem.
266:8784–8789. 1991.PubMed/NCBI
|
|
37
|
Luo S, Wang X and Sun X: The expression
and clinical significance of p16 and nm23 in cervical carcinoma.
Zhong Guo Shi Yong Fu Ke Yu Chan Ke. 7:421–422. 2004.In
Chinese.
|
|
38
|
Utrera-Barillas D, Salcedo-Vargas M,
Gariglio-Vidal P, Hernández-Hernández DM, Gutiérrez-Delgado F and
Benítez-Bribiesca L: H-ras and Nm23-H1 gene expression and
proteolytic activity in squamous cell carcinoma of the uterine
cervix. Arch Med Res. 31:172–181. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wu W, Xu H and Deng Z: Expression of
nm23H1 and E-cadherin protein in 39 cases of endometrial carcinoma.
Zhong Liu Xue Zazhi. 4:322–323. 2006.
|
|
40
|
Ding GF, Li JC and Xu YF: Study on the
correlationship between the expression of nm23H1mRNA, TGF-beta1mRNA
and tumor metastases, survival rate with prostate cancer. Fen Zi Xi
Bao Sheng Wu Xue Bao. 39:544–552. 2006.In Chinese.
|
|
41
|
Nicholson KM and Anderson NG: The protein
kinase B/Akt signalling pathway in human malignancy. Cell Signal.
14:381–395. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Li Q and Zhu GD: Targeting
serine/threonine protein kinase B/Akt and cell-cycle checkpoint
kinases for treating cancer. Curr Top Med Chem. 2:939–971. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Elstrom RL, Bauer DE, Buzzai M, Karnauskas
R, Harris MH, Plas DR, Zhuang H, Cinalli RM, Alavi A, Rudin CM and
Thompso CB: Akt stimulates aerobic glycolysis in cancer cells.
Cancer Res. 64:3892–3899. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kim D, Kim S, Koh H, Yoon SO, Chung AS,
Cho KS and Chung J: Akt/PKB promotes cancer cell invasion via
increased motility and metalloproteinase production. FASEB J.
15:1953–1962. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Huang Y, Cai S and Yu S: Relationship
between nm23-H1 expression and lymph node metastasis and prognosis
in cervical cancer. Zhonghua Fu Chan Ke Za Zhi. 32:718–721. 1997.In
Chinese.
|
|
46
|
Utrera-Barillas D, Salcedo-Vargas M,
Gariglio-Vidal P, Hernández-Hernández DM, Gutiérrez-Delgado F and
Benítez-Bribiesca F: H-ras and nm23-H1 gene expression and
proteolytic activity in squamous cell carcinoma of the uterine
cervix. Arch Med Res. 31:172–181. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Tong Y, Yung LY and Wong YH: Metastasis
suppressors nm23H1 and nm23H2 differentially regulate neoplastic
transformation and tumorigenesis. Cancer Lett. 361:207–217. 2015.
View Article : Google Scholar : PubMed/NCBI
|
